How does SARS-CoV-2 N protein phase separation specifically disrupt cGAS-G3BP1 assembly at the molecular level?

OPEN

The abstract shows N protein undergoes LLPS to disrupt cGAS-G3BP1 complex formation, but the precise molecular mechanisms of this disruption remain unclear. Understanding these mechanisms could reveal therapeutic targets for preserving innate immunity during viral infection. Gap type: unexplained_observation Source paper: Phase-separated nucleocapsid protein of SARS-CoV-2 suppresses cGAS-DNA recognition by disrupting cGAS-G3BP1 complex. (2023, Signal transduction and targeted therapy, PMID:37100798)

Priority: 0.80 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How does SARS-CoV-2 N protein phase separation specifically disrupt cGAS-G3BP1 assembly at the molecular level? is a 0.8 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How does SARS-CoV-2 N protein phase separation specifically disrupt cGAS-G3BP1 assembly at the molecular level? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (3)

G3BP1PI3K/Akt signalingIntracellular Free RnaG3BP1G3BP1Stress Granules

associated with (4)

G3BP1Stress GranulesSARS-CoV-2Bone Marrow Plasma CellsTMPRSS2SARS-CoV-2G3BP1STRESS GRANULE

binds (2)

Nsp3G3BP1ACE2SARS-CoV-2

causes (3)

SARS-CoV-2Microglia DysfunctionSARS-CoV-2Neurological SequelaeSARS-CoV-2Bone Marrow Plasma Cells

component of (2)

G3BP1Stress GranuleG3BP1Stress Granules

encodes (1)

G3BP1G3BP1

expressed in (1)

hiPSC-derived lung organoidG3BP1

inhibits (1)

G3BP1axonal mRNA translation

interacts with (4)

G3BP1SLU7G3BP1LINC00599LINC00599G3BP1G3BP1Stress Granule

involved in (6)

G3BP1stress granule-like structuresG3BP1Stress Granule FormationG3BP1stress granule formationG3BP1STRESS GRANULE DISASSEMBLYG3BP1Stress Granule
▸ Show 1 more

mediates (7)

G3BP1Liquid-Liquid Phase SeparationG3BP1Stress Granule FormationUBIQUITING3BP1G3BP1Stress Granule DisassemblyG3BP1LIQUID-LIQUID PHASE SEPARATION
▸ Show 2 more

modulates (4)

UBIQUITINATIONG3BP1UbiquitinationG3BP1PHOSPHORYLATIONG3BP1SARS-CoV-2UBIQUITIN

phosphorylates (1)

TRIM21G3BP1

promotes (1)

G3BP1immune evasion

protects against (2)

Anti-Receptor Binding Domain AntibodiesSARS-CoV-2Anti-receptor Binding Domain AntibodiesSARS-CoV-2

regulates (4)

G3BP1STRESS GRANULE ASSEMBLYubiquitinationG3BP1G3BP1STRESS GRANULE-SPECIFIC INTERACTION NETWORKG3BP1Ribonucleoprotein Granules

risk factor for (1)

G3BP1anti-PD-1 therapy response

targets (3)

h-ec731b7aG3BP1h-fffd1a74G3BP1h-97aa8486G3BP1
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps